Eculizumab to Cemdisiran Switch in aHUS

Clinical trial NCT03999840 · WITHDRAWN

Trial details

NCT number: NCT03999840
Sponsor: Mario Negri Institute for Pharmacological Research
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Atypical Hemolytic Uremic Syndrome

Start date: 2021-01-01
Primary completion: 2024-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.